1. JAK/STAT Signaling Stem Cell/Wnt Apoptosis Anti-infection
  2. STAT Ferroptosis Parasite Virus Protease
  3. Artesunate

Artesunate  (Synonyms: 青蒿琥酯)

目录号: HY-N0193 纯度: 99.84%
COA 产品使用指南

Artesunate 是 STAT-3 和输出蛋白 1 (EXP1) 的抑制剂。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Artesunate Chemical Structure

Artesunate Chemical Structure

CAS No. : 88495-63-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥550
In-stock
50 mg ¥500
In-stock
100 mg ¥800
In-stock
200 mg ¥1360
In-stock
500 mg   询价  
1 g   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Artesunate:

    Artesunate purchased from MCE. Usage Cited in: Basic Clin Pharmacol Toxicol. 2022 Nov 26.  [Abstract]

    Artesunate (ART; 1, 2 μM) significantly reduces cell viability in RAW264.7 cells in the presence of RANKL but does not influence undifferentiating cells.
    • 生物活性

    • 实验参考方法

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).

    IC50 & Target[1][2]

    Stat-3

     

    EXP1

     

    细胞效力
    (Cellular Effect)
    Cell Line Type Value Description References
    A549 IC50
    15.921 μM
    Compound: 1; ART
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    A549 IC50
    5.4 μM
    Compound: 3; ARS
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    A549 IC50
    50.68 μM
    Compound: ATS
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    ADR5000 cell line EC50
    0.1 μM
    Compound: 2
    Cytotoxicity against human CEM/ADR5000 cells overexpressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CEM/ADR5000 cells overexpressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29937978]
    ADR5000 cell line EC50
    0.189 μM
    Compound: 3
    Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29887512]
    ADR5000 cell line IC50
    0.19 μM
    Compound: 3
    Cytotoxicity against human CEM/ADR5000 cells assessed as cell viability after 72 hrs by resazurin assay
    Cytotoxicity against human CEM/ADR5000 cells assessed as cell viability after 72 hrs by resazurin assay
    [PMID: 26260339]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 1
    Cytotoxicity against human CEM/ADR5000 by CCK-8 assay
    Cytotoxicity against human CEM/ADR5000 by CCK-8 assay
    [PMID: 22884578]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 2
    Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay
    Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay
    [PMID: 24561670]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 1
    Cytotoxicity against human CEM/ADR5000 by XTT assay
    Cytotoxicity against human CEM/ADR5000 by XTT assay
    [PMID: 20527917]
    BT-474 IC50
    7.8 μM
    Compound: Artesunate
    Cytotoxicity against human BT474 cells after 48 hrs by MTT assay
    Cytotoxicity against human BT474 cells after 48 hrs by MTT assay
    [PMID: 23790541]
    C-33-A EC50
    1.83 μM
    Compound: 7
    Antiproliferative activity against human C33A cells after 72 hrs by MTT assay
    Antiproliferative activity against human C33A cells after 72 hrs by MTT assay
    [PMID: 30429957]
    CCRF-CEM EC50
    0.069 μM
    Compound: 3
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29887512]
    CCRF-CEM IC50
    0.07 μM
    Compound: 3
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 72 hrs by resazurin assay
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 72 hrs by resazurin assay
    [PMID: 26260339]
    CCRF-CEM EC50
    0.4 μM
    Compound: 2
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29937978]
    CCRF-CEM IC50
    1.8 μM
    Compound: 1
    Cytotoxicity against human CCRF-CEM cells by CCK-8 assay
    Cytotoxicity against human CCRF-CEM cells by CCK-8 assay
    [PMID: 22884578]
    CCRF-CEM IC50
    1.8 μM
    Compound: 2
    Cytotoxicity against human CCRF-CEM cells by resazurin assay
    Cytotoxicity against human CCRF-CEM cells by resazurin assay
    [PMID: 24561670]
    CCRF-CEM IC50
    1.8 μM
    Compound: 1
    Cytotoxicity against human CCRF-CEM by XTT assay
    Cytotoxicity against human CCRF-CEM by XTT assay
    [PMID: 20527917]
    CHO IC50
    > 100 μM
    Compound: ARS
    Cytotoxicity against CHO cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Cytotoxicity against CHO cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    [PMID: 27448920]
    HCT-116 IC50
    0.89 μM
    Compound: AS
    Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    [PMID: 31494469]
    HCT-116 IC50
    7.1 μM
    Compound: Artesunate
    Antiproliferative activity against human HCT-116 cells assessed as growth after 48 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells assessed as growth after 48 hrs by MTT assay
    [PMID: 27010926]
    HEK293 IC50
    10 μM
    Compound: Artesunate
    Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    [PMID: 28774427]
    HEK293 IC50
    2.9 μM
    Compound: artesunate
    Cytotoxicity against human HEK293 cells after 72 hrs by alamar blue assay
    Cytotoxicity against human HEK293 cells after 72 hrs by alamar blue assay
    [PMID: 21155593]
    HEK293 IC50
    7 μM
    Compound: Artesunate
    Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay
    Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay
    [PMID: 29236492]
    HeLa IC50
    0.5 μM
    Compound: Artesunate
    Cytotoxicity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay
    [PMID: 31945642]
    HeLa EC50
    12.03 μM
    Compound: 7
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    [PMID: 30429957]
    HeLa IC50
    19.014 μM
    Compound: 1; ART
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HeLa IC50
    3.2 μM
    Compound: Artesunate
    Cytotoxicity against human HeLa cells incubated for 48 hrs by resazurin dye reduction assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by resazurin dye reduction assay
    [PMID: 23013253]
    HeLa IC50
    7.1 μM
    Compound: Artesunate
    Antiproliferative activity against human Hela cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Antiproliferative activity against human Hela cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 27010926]
    HepG2 IC50
    < 1 μM
    Compound: Artesunate
    Antimalarial activity against sporozoite stage of Plasmodium yoelii assessed as invasion of human HepG2 cells expressing CD81 incubated for 2 hrs prior to inoculation measured after 1 hr by immunofluorescence assay in presence of penicillin/streptomycin
    Antimalarial activity against sporozoite stage of Plasmodium yoelii assessed as invasion of human HepG2 cells expressing CD81 incubated for 2 hrs prior to inoculation measured after 1 hr by immunofluorescence assay in presence of penicillin/streptomycin
    [PMID: 23927658]
    HepG2 IC50
    12.7 μM
    Compound: artesunate
    Cytotoxicity against human HepG2 cells after 72 hrs by alamar blue assay
    Cytotoxicity against human HepG2 cells after 72 hrs by alamar blue assay
    [PMID: 21155593]
    HepG2 IC50
    20 μM
    Compound: ARS
    Cytotoxicity against human HepG2 cells after 72 hrs by formazan test
    Cytotoxicity against human HepG2 cells after 72 hrs by formazan test
    [PMID: 23685181]
    HepG2 IC50
    22.24 μM
    Compound: 1; ART
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HepG2 IC50
    267 μM
    Compound: Artesunate
    Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
    [PMID: 33158577]
    HepG2 IC50
    39.93 μM
    Compound: ATS
    Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    HepG2 IC50
    47 μM
    Compound: 3; ARS
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    HepG2 IC50
    59.4 μM
    Compound: Artesunate
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    [PMID: 31546197]
    HepG2 IC50
    6.5 μM
    Compound: ART
    Dark toxicity against human HepG2 cells assessed as reduction in cell viability incubated overnight by MTT assay
    Dark toxicity against human HepG2 cells assessed as reduction in cell viability incubated overnight by MTT assay
    [PMID: 28882481]
    HepG2 IC50
    7.7 μM
    Compound: ART
    Phototoxicity against human HepG2 cells assessed as reduction in cell viability preincubated overnight followed by irradiation with LED light at 1.7 J/cm'2 for 10 mins measured post overnight incubation by MTT assay
    Phototoxicity against human HepG2 cells assessed as reduction in cell viability preincubated overnight followed by irradiation with LED light at 1.7 J/cm'2 for 10 mins measured post overnight incubation by MTT assay
    [PMID: 28882481]
    HepG2 2.2.15 IC50
    2.3 μM
    Compound: 21
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days
    [PMID: 24549242]
    HL-60 IC50
    2 μM
    Compound: ASN
    Cytotoxicity against human HL60 cells assessed as cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 24 hrs by MTT assay
    [PMID: 24148834]
    Huh-7 CC50
    > 100 μg/mL
    Compound: AS
    Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    [PMID: 36306538]
    HUVEC IC50
    1.092 μM
    Compound: 1; ART
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HUVEC IC50
    86.1 μM
    Compound: 3; ARS
    Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    J82 IC50
    75.7 μM
    Compound: 3; ARS
    Cytotoxicity in human J82 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity in human J82 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    K562 IC50
    5.999 μM
    Compound: 1; ART
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    K562/Adr IC50
    6.256 μM
    Compound: 1; ART
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    KB IC50
    78.5 μM
    Compound: Artesunate
    Antiproliferative activity against human KB cells by MTT assay
    Antiproliferative activity against human KB cells by MTT assay
    [PMID: 31546197]
    L02 IC50
    72.17 μM
    Compound: ATS
    Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    L6 IC50
    1.5 μM
    Compound: Artesunate
    Cytotoxicity against rat L6 cells incubated for 690 hrs by Alamar blue assay
    Cytotoxicity against rat L6 cells incubated for 690 hrs by Alamar blue assay
    [PMID: 23013253]
    L6 IC50
    24 μM
    Compound: AS
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay
    [PMID: 25195945]
    L6 IC50
    6.63 μM
    Compound: 2
    Cytotoxicity in rat L6 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based assay
    Cytotoxicity in rat L6 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based assay
    [PMID: 28988153]
    LS174T IC50
    10 μM
    Compound: ARS
    Cytotoxicity against human LS 174T cells after 72 hrs by formazan test
    Cytotoxicity against human LS 174T cells after 72 hrs by formazan test
    [PMID: 23685181]
    MCF-10A IC50
    21 μM
    Compound: Artesunate
    Cytotoxicity against human MCF10A cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF10A cells after 48 hrs by MTT assay
    [PMID: 23790541]
    MCF7 IC50
    38.71 μM
    Compound: ATS
    Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    MCF7 EC50
    4.21 μM
    Compound: 7
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MDA-MB-231 EC50
    10.04 μM
    Compound: 7
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MDA-MB-231 IC50
    46 μM
    Compound: Artesunate
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    [PMID: 23790541]
    MDA-MB-231 IC50
    75.69 μM
    Compound: ATS
    Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    MDA-MB-361 EC50
    2.27 μM
    Compound: 7
    Antiproliferative activity against human MDA-MB-361 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-361 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MRC5 IC50
    6.8 μM
    Compound: Artesunate
    Cytotoxicity against human MRC5 cells incubated for 48 hrs by resazurin dye reduction assay
    Cytotoxicity against human MRC5 cells incubated for 48 hrs by resazurin dye reduction assay
    [PMID: 23013253]
    OVCAR-3 IC50
    67.3 μM
    Compound: 3; ARS
    Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    SiHa EC50
    > 30 μM
    Compound: 7
    Antiproliferative activity against human SiHa cells after 72 hrs by MTT assay
    Antiproliferative activity against human SiHa cells after 72 hrs by MTT assay
    [PMID: 30429957]
    SK-HEP1 IC50
    10 μM
    Compound: ARS
    Cytotoxicity against human SKHEP1 cells after 72 hrs by formazan test
    Cytotoxicity against human SKHEP1 cells after 72 hrs by formazan test
    [PMID: 23685181]
    SMMC-7721 IC50
    72.3 μM
    Compound: 3; ARS
    Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    T47D EC50
    2.22 μM
    Compound: 7
    Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
    Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
    [PMID: 30429957]
    WI-38 IC50
    > 100 μM
    Compound: ARS
    Cytotoxicity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    Cytotoxicity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    [PMID: 27448920]
    WI-38 IC50
    > 100 μM
    Compound: Artesunate
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay
    [PMID: 27210430]
    WM 266-4 IC50
    8.46 μM
    Compound: AS
    Antiproliferative activity against human WM266.4 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    Antiproliferative activity against human WM266.4 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    [PMID: 31494469]
    体外研究
    (In Vitro)

    Artesunate 是 STAT-3 和输出蛋白 1 (EXP1) 的抑制剂[1][2]。Artesunate 处理 24 小时会导致两种细胞系中活性氧 (ROS) 水平以剂量依赖性方式显著增加。此外,蛋白质印迹法显示,当癌细胞在较高剂量范围内用 Artesunate 处理 24 小时时,γ-H2AX 水平显著升高。Artesunate 还表现出对 A2780 和 HO8910 细胞中 RAD51 水平的时间依赖性影响。在两种非恶性细胞(正常人成纤维细胞和永生化上皮细胞 FTE-187)中,Artesunate 不会改变 RAD51 的水平。在 A2780 细胞中,RAD51 mRNA 水平确实因 Artesunate 的加入而降低,且呈剂量依赖性。相应地,RAD51 的启动子活性被青蒿琥酯显著抑制。相反,H8910 细胞中的 RAD51 mRNA 水平不受 Artesunate 的影响[3]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    体内研究
    (In Vivo)

    Artesunate 与顺铂联合治疗组肿瘤生长明显减少(P<0.01)。相比之下,Artesunate 单独治疗对两种细胞系肿瘤异种移植的生长无显著影响[3]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    分子量

    384.42

    Formula

    C19H28O8

    CAS 号
    性状

    固体

    颜色

    White to off-white

    中文名称

    青蒿酯;青蒿琥酯;二氢青蒿素-12-α-丁二酸单酯;

    结构分类
    初始来源
    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    溶解性数据
    细胞实验: 

    DMSO 中的溶解度 : 83.33 mg/mL (216.77 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

    7.5% Sodium bicarbonate 中的溶解度 : 2 mg/mL (5.20 mM; 超声助溶 (<60°C))

    H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 2.6013 mL 13.0066 mL 26.0132 mL
    5 mM 0.5203 mL 2.6013 mL 5.2026 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物实验:

    请根据您的 实验动物和给药方式 选择适当的溶解方案。

    以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
    ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
    以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

    • 方案 一

      请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (5.41 mM); 澄清溶液

      此方案可获得 ≥ 2.08 mg/mL(饱和度未知)的澄清溶液。

      1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

      生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
    • 方案 二

      请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (5.41 mM); 澄清溶液

      此方案可获得 ≥ 2.08 mg/mL(饱和度未知)的澄清溶液。

      1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

      2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。
    动物溶解方案计算器
    请输入动物实验的基本信息:

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    由于实验过程有损耗,建议您多配一只动物的量
    请输入您的动物体内配方组成:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
    方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
    计算结果
    工作液所需浓度 : mg/mL
    储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。
    您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
    动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
    连续给药周期超过半月以上,请谨慎选择该方案。
    请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
    纯度 & 产品资料

    纯度: 99.84%

    参考文献
    Kinase Assay
    [3]

    After treatment with Artesunate for 24 h, cells are harvested and lysed in 1×cell lysis buffer. Total proteins of 15 to 25 μg are separated by SDS-PAGE and transferred to polyvinylidenedifluoride (PVDF) membranes. Membranes are blocked with 5% non-fat milk for 1 to 2 h at room temperature and then probed with primary antibodies and incubated at 4°C overnight. After extensive washing with TBS-T, membranes are incubated with appropriate HRP-conjugated secondary antibody for 1 h at room temperature, and then are detected by Western ECL-enhanced luminol reagent [3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Assay
    [3]

    A2780 and HO8910 cells are cultured in RPMI 1640, Normal human fibroblasts (NHF) in DMEM, and FTE-187 in M199, supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 mg/mL streptomycin. All the cells are incubated in a humidified atmosphere of 95% air and 5% CO2. Artesunate is applied to the cultured cells at the concentration of 0, 5, 10, 25, or 50 µg/mL for various periods. The reactive oxygen species (ROS) production following Artesunate treatment is determined. Briefly, cells are loaded with 5 μM of CM-H2DCFDA and incubated at 37°C for 20 min after treatment with Artesunate. Cells are resuspended using preserving fluid and analyzed with a FACSCanto II. The peak excitation wavelength for oxidized CM-H2DCFDA is 490 nm and emission is 530 nm[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3]

    Four to six weeks old female athymic nude mice (BALB/c, nu/nu) are used. A2780 and HO8910 cells are harvested and resuspended in 0.1 ml of PBS, 5×106 cells/0.2 mL are injected subcutaneously into the left inguinal area of the mice. Two weeks later, mice bearing tumors (~70 mm3 for A2780 and HO8910) are randomly divided into 4 groups. Artesunate is administered daily via i.p. injection at doses of 50 mg/kg alone for 16 days. The tumor growth is monitored every other day. Tumor volume is determined by the formula 1/2a×b2 where a is the long diameter (mm) and b is the short diameter (mm)[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    参考文献

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    7.5% Sodium bicarbonate / DMSO 1 mM 2.6013 mL 13.0066 mL 26.0132 mL 65.0330 mL
    5 mM 0.5203 mL 2.6013 mL 5.2026 mL 13.0066 mL
    DMSO 10 mM 0.2601 mL 1.3007 mL 2.6013 mL 6.5033 mL
    15 mM 0.1734 mL 0.8671 mL 1.7342 mL 4.3355 mL
    20 mM 0.1301 mL 0.6503 mL 1.3007 mL 3.2517 mL
    25 mM 0.1041 mL 0.5203 mL 1.0405 mL 2.6013 mL
    30 mM 0.0867 mL 0.4336 mL 0.8671 mL 2.1678 mL
    40 mM 0.0650 mL 0.3252 mL 0.6503 mL 1.6258 mL
    50 mM 0.0520 mL 0.2601 mL 0.5203 mL 1.3007 mL
    60 mM 0.0434 mL 0.2168 mL 0.4336 mL 1.0839 mL
    80 mM 0.0325 mL 0.1626 mL 0.3252 mL 0.8129 mL
    100 mM 0.0260 mL 0.1301 mL 0.2601 mL 0.6503 mL
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    Artesunate
    目录号:
    HY-N0193
    需求量: